Search by Practice
Insights & News / Corporate Finance
December 22, 2025
Barnea: Representing Syremis in a USD 165 Million Investment Round
Adv. Michael Barnea, Adv. Misha Gitterman, and Adv. Tal Freilich represented Syremis Therapeutics, a spin-off of Clexio Biosciences, in the completion of a USD 165 million Series A financing round co-led by Dexcel Pharma and Third Rock Ventures, with participation from Bain Capital Life Sciences, Google Ventures, and QVT.
July 3, 2025
Mergers and Acquisitions – A Professional Lecture for CFOs by MAI
Adv. Ilan Blumenfeld, a partner and head of the Israeli commercial practice in the firm's Corporate Department, delivered the lecture “The Legal Aspects of Mergers and Acquisitions: Preparing a Company for Sale and/or Merger” as part of the CFO training program organized by the Manufacturers Association of Israel (MAI).
May 19, 2025
Doral Renewables Secures USD 1.3 Billion Financing for Major US Solar Projects
Doral Renewables has successfully closed a landmark USD 1.3 billion financing agreement with HSBC, Santander, and KeyBank to support the development of three of the largest solar energy projects ever built in the United States. Advs. Samuel Henri Samuel and Nir Alter from our International Commercial Department represented the Doral Group and Migdal entities in this significant US transaction.
March 31, 2024
Representing One Peak in USD 100 Million Financing Round
Simon Jaffa, Yuval Lazi, Mayer Winkler, Tal Freilich, Nofar Rose David, and Dana Ben Yehuda represented UK-based investment management firm One Peak Partners in its investment in Coro, an Israeli cybersecurity startup.
December 7, 2022
Stock Market Skeletons: Dudi Cohen Interview with Globes
Stock market skeletons are raising their heads. Recently, several skeleton companies have announced talks about merging with private companies who have substantial activity. Dudi Cohen, head of our firm’s Finance and Public Corporations Department, was interviewed by Globes on the phenomenon. He shed some light on the issue of stock market skeletons and the legal problems that may arise as a result.
November 30, 2022
Shareholder Transactions – Elad Reshtick Lecture
Elad Reshtick, a firm partner, lectured to members of a senior business management course on the do’s and don’ts of shareholder transactions. He delivered the lecture to the IDF unit of the Gender Affairs Advisor to the Chief of Staff in cooperation with the Israeli Directors’ Union.
May 3, 2020
Capital Markets in the Age of Coronavirus
An MA expert, Micky Barnea was interviewed by the leading newspaper Globes as part of an extensive analysis on the long list of major deals that are being canceled and the financial uncertainty in this period. The article highlights how huge corporations are able to afford what little companies and the self-employed can only dream of. According to Micky, "Starting in February, we noticed a phenomenon in which time has become elastic. Usually people strive to keep deals at a steady pace, and once the handshake is made, they want to move faster. Now, less people are hurrying to complete a deal. They are taking time to see what will happen next in the market.”
March 19, 2020
Coronavirus: Is a Huge Wave of Debt Arrangement on the Way?
Micky Barnea was interviewed by Globes on the coronavirus’ effect on both the corporate and government bond markets.
March 29, 2017
Barnea & Co. Represented Viola Private Equity in an Investment in Similar Web
Barnea represented Viola Private Equity in an investment of USD 50 million in Similar Web, a leading digital market intelligence platform that provides insights for websites and applications.
April 5, 2017
Barnea & Co. represented Avgol in issuance of a New Series of Bonds
Barnea represented Avgol Industries 1953 Ltd in connection with the issuance of a new series of bonds in the amount of NIS 197 Million. Avgol is one of the biggest manufacturers in the world of non-woven fabrics for the hygiene market. Its securities are traded in the leading indices on the Tel Aviv Stock Exchange.